HIV infection risk behaviors and methadone treatment: Client-reported hiv infection in a follow-up study of injecting drug users in New England

American Journal of Drug and Alcohol Abuse

Volumn 23, Issue 3, 1997, Pages 397-411

  Brackbill, Robert M ^a   MacGowan, Robin J ^a   Rugg, Deborah ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Follow up studies; Human immunodecifiency virus; Incidence; Intravenous drug users; Methadone treatment; Risk factors; Sexual behavior

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; METHADONE; COCAINE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; SEXUAL BEHAVIOR; UNITED STATES; ADDICTION; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; DRUG ABUSE; HEROIN DEPENDENCE; INCIDENCE; PROSPECTIVE STUDY; RISK; SEXUALITY; STATISTICS; SUBSTANCE ABUSE;

ADULT; COCAINE; CONFIDENCE INTERVALS; CONNECTICUT; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MASSACHUSETTS; METHADONE; NEEDLE SHARING; PROSPECTIVE STUDIES; RISK; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 0030612328     PISSN: 00952990     EISSN: None     Source Type: Journal    
DOI: 10.3109/00952999709016885     Document Type: Article

References (29)

1. Nicolosi, A., Musicco, M., Sarocco, A., et al., Incidence and risk factors of HIV infection: A prospective study of seronegative drug users from Milan and Northern Italy, 1987-1989, Epidemiology 1:453-459 (1990).
2. Schoenbaum, E. E., Hartel, D., Selwyn, P. A., et al., Risk factors for Human Immunodeficiency Virus infection in intravenous drug users, N. Engl. J. Med. 321:874-879 (1989).
3. Des Jarlais, D. C., Choopanya, K., Vanichseni, S., et al., AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok, Am. J. Public Health 84:452-455 (1994).
4. Metzger, D. S., Woody, G. E., McLellan, T., et al., Human Immunodeficiency Virus seroconversion among intravenous drug uses in- and out-of-treatment: An 18-month prospective follow-up, J. Acquir. Immun. Defic. Syndr. 6:1049-1056 (1993).
5. Zangerle R., Fuchs, D., Rossler, H., et al., Trends in HIV infection among intravenous drug users in Innsbruck, Austria, J. Acquir. Immun. Defic. Syndr. 5:865-871 (1992).
6. Friedman, S. R., Benny, J., Deren, S., et al., Risk factors for Human Immunodeficiency Virus Seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities, Am. J. Epidemiol. 142:864-874 (1995).
7. van Ameijden, E. J. C., van den Hoek, J. A. R., van Haastrecht, H. J. A., et al., The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam, Am. J. Epidemiol. 136:236-243 (1992).
8. Nicolosi, A., Leite, M. L. C., Musicco, M., et al., Parenteral and sexual transmission of Human Immunodeficiency Virus in intravenous drug users: A study of seroconversion, Am. J. Epidemiol. 135:225-233 (1992).
9. Moss, A. R., Vranizan, K., Gorter, R., et al., HIV seroconversion in intravenous users in San Francisco, 1985-1990, AIDS, 8:223-231 (1994).
10. Astemborski, J., Vlahov, D., Warren, D., et al., The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users, Am. J. Public Health 84:382-387 (1994).
11. AIDS in Connecticut, Annual Surveillance Report, December 31, 1992.
12. Massachusetts Department of Health, AIDS Surveillance Program 1992.
13. Holmberg, S. D., The estimated prevalence and incidence of HIV in 96 large metropolitan areas, Am. J. Public Health 86:642-654 (1996).
14. Swanson, N., Patton, C., McNamara, R., et al., HIV counseling and testing evaluation study: Ethnographic component final report, January 1994, Unpublished Data.
15. Centers for Disease Control, Risk behaviors for HIV transmission among intravenous-drug users not in treatment - United States, 1987-1989, MMWR Morb Mortal Wkly Rep. 39:273-276 (1990).
16. Selvin, S., Statistical Analysis of Epidemiologic Data, Oxford University Press, 1991.
17. PHREG procedure, SAS Technical Report P-229 SAS/STAT Software: Changes and Enhancements, Release 6.07, SAS Institute, Cary, North Carolina, 1991.
18. Solomon, L., Astemborski, J., Warren, D., et al., Differences in risk factors for human immunodeficiency virus Type 1 seroconversion among male and female intravenous drug users, Am. J. Epidemiol. 137:892-8 (1993).
19. Hahn, R. A., Onorato, I. M., Jones, S. T., et al., Prevalence of HIV infection among intravenous drug users, JAMA 261:2677-2684 (1989).
20. Robles, R. R., Colon, H. M., Sahai, H., et al., Behavioral risk factors and Human Immunodeficiency Virus prevalence among intravenous drug users in Puerto Rico, Am. J. Epidemiol. 135:531-540 (1992).
21. Chaisson, R. E., Bacchetti, P., and Osmond, D., Cocaine use and HIV infection in intravenous drug users in San Francisco, JAMA 261:561-565 (1989).
22. Massachusetts Department of Public Health - AIDS Bureau, HIV Seropositivity Follow-up/ CISS Program, 1993 CICS Aggregate Report, March 21, 1994.
23. Vlahov, D., HIV seroconversion studies among intravenous drug users, AIDS 8:263-265 (1994).
24. Battjes, R. J., Pickens, R. W., Amsel, Z., et al., Heterosexual transmission of Human Immunodeficiency Virus among intravenous drug users, J. of Inf. Diseases 162:1007-1011 (1990).
25. Chaisson, R. E., Moss, A. R., Onishi, R., et al., Human Immunodeficiency Virus infection in heterosexual intravenous drug users in San Francisco, Am. J. Public Health 77:169-172 (1987).
26. McCusker, J., Stoddard, A. M., and McCarthy, E., The validity of self-reported HIV antibody test results, Am. J. Public Health 82:567-569 (1992).
27. Schutz, C. G., Vlahov, D., Anthony, J. C., et al., Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users, J. Clin. Epidemiol. 47:191-195 (1994).
28. Anthony, J. C., Vlahov, D., Celentano, D. D., et al., Self-report interview data for a study of HIV-1 infection among intravenous drug users: Description of methods and preliminary evidence on validity, J. Drug Issues 21:739-757 (1991).
29. Ehrman, R. M., Robbins, S. J., Reliability and validity of 6-month timeline reports of cocaine and heroin use in a methadone population, J. Consult. Clin. Psychology 62:843-850 (1994).